Emvose Trio 2 mg/500 mg/0.2 mg Tablet

Medo Pharma

SALT COMPOSITION

Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)

Emvose

Rx Prescription Required

Potentially unsafe with Alcohol

MRP 144  10% off
130

12.96/Tablets
Strip of 10 Tablets

Medicine Overview of Emvose Trio 2 mg/500 mg/0.2 mg Tablet

Overview
Introduction
Emvose Trio 2 Mg/500 Mg/0.2 Mg Tablet Is Used In The Treatment Of Type 2 Diabetes. It Is A Combination Of Two Medicines That Effectively Control Blood Sugar Levels, When A Single Medication Is Not Effective. It Should Be Used Along With Proper Diet And Regular Exercise For Best Results. Monitor Your Blood Sugar Level Regularly While You Are Taking This Medicine As It May Cause Hypoglycemia (low Blood Sugar Level).
Uses Of Emvose Trio Tablet

    Type 2 Diabetes Mellitus

In Depth Information of Emvose Trio 2 mg/500 mg/0.2 mg Tablet

Emvose Trio Tablet side effects
Common

    Hypoglycemia (low blood sugar level)
    Nausea
    Diarrhea
    Taste change
    Flatulence
    Stomach pain
    Headache
    Skin rash
    Respiratory tract infection

How to use Emvose Trio Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Emvose Trio 2 mg/500 mg/0.2 mg Tablet is to be taken with food.
Emvose Trio 2 mg/500 mg/0.2 mg Tablet may cause stomach upset if taken on empty stomach.
How Emvose Trio Tablet works
Emvose Trio 2 mg/500 mg/0.2 mg Tablet is a combination of three antidiabetic medicines: Glimepiride, metformin and voglibose. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glimepiride is a sulfonylurea which works by increasing the amount of insulin released by the pancreas to lower the blood glucose. Metformin is a biguanide which lowers glucose production in the liver, delays glucose absorption from intestines and increases the body's sensitivity to insulin. Voglibose is an alpha-glucosidase inhibitor which prevents breakdown of complex sugars into simple sugars such as glucose. This prevents the blood glucose levels from rising to very high levels after meals.

Emvose Trio 2 mg/500 mg/0.2 mg Tablet related warnings

Emvose Trio Tablet related warnings
warnings
Alcohol
UNSAFE
It is unsafe to consume alcohol with Emvose Trio 2 mg/500 mg/0.2 mg Tablet Taking Voglibose with alcohol reduce the blood sugar levels in diabetic patients.
warnings
Pregnancy
CONSULT YOUR DOCTOR
Emvose Trio 2 mg/500 mg/0.2 mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
warnings
Lactation
SAFE IF PRESCRIBED
Emvose Trio 2 mg/500 mg/0.2 mg Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
warnings
Driving
CAUTION
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
warnings
Kidney
CAUTION
Emvose Trio 2 mg/500 mg/0.2 mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Emvose Trio 2 mg/500 mg/0.2 mg Tablet may be needed. Please consult your doctor.
Use of Emvose Trio 2 mg/500 mg/0.2 mg Tablet is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
warnings
Liver
CAUTION
Emvose Trio 2 mg/500 mg/0.2 mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Emvose Trio 2 mg/500 mg/0.2 mg Tablet may be needed. Please consult your doctor.
Emvose Trio 2 mg/500 mg/0.2 mg Tablet is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.

Substitutes for Emvose Trio 2 mg/500 mg/0.2 mg Tablet

About Emvose Trio 2 mg/500 mg/0.2 mg Tablet